Metadate Cd
Narcolepsy, Attention Deficit Hyperactivity Disorder
Treatment
20 Active Studies for Metadate Cd
Treatment for
Narcolepsy
What is Metadate Cd
Methylphenidate
The Generic name of this drug
Treatment Summary
Methylphenidate is a stimulant medication used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) and narcolepsy. It is sold under the brand names Ritalin, Concerta, and Biphentin and is typically used with other therapies such as psychological, educational, and cognitive behavior therapy to improve symptoms like distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. Methylphenidate works by increasing the presence of norepinephrine and dopamine in the brain. It is generally safe and effective and can be prescribed to both adults and children. However, it has
Methylphenidate Hydrochloride
is the brand name
Metadate Cd Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Methylphenidate Hydrochloride
Methylphenidate
1955
490
Effectiveness
How Metadate Cd Affects Patients
Methylphenidate is a drug that contains two different components, the d- and l-isomers. The d-isomer is more effective than the l-isomer in producing its effects. Studies have shown that it binds to dopamine-rich areas of the brain, especially in the prefrontal cortex, which is involved in ADHD. In animals, methylphenidate has been shown to increase physical activity and cause repetitive behaviors.
How Metadate Cd works in the body
Methylphenidate works by increasing the amount of norepinephrine and dopamine in the brain. This can help improve attention and memory, which is especially beneficial for people with ADHD. It is believed that methylphenidate helps by filling the gaps caused by genetic abnormalities in the dopamine transporter gene, D4 receptor gene, and D2 receptor gene. Higher doses increase activity throughout the brain, while lower doses more selectively target the prefrontal cortex, which is important for ADHD. Additionally, methylphenidate's abilities to reduce impulsivity and movement are due to its effects on alpha-1 adrenergic receptors.
When to interrupt dosage
The proposed measure of Metadate Cd is contingent on the recognized affliction. The amount of dosage fluctuates, as per the technique of delivery specified in the table below.
Condition
Dosage
Administration
Attention Deficit Hyperactivity Disorder
20.0 mg, , 30.0 mg, 40.0 mg, 10.0 mg, 60.0 mg, 27.0 mg, 36.0 mg, 54.0 mg, 50.0 mg, 5.0 mg, 2.5 mg, 5.0 mg/mL, 10.0 mg/mL, 18.0 mg, 80.0 mg, 15.0 mg, 10.0 mg/hour, 20.0 mg/hour, 15.0 mg/hour, 30.0 mg/hour, 30.0 mg/mL, 6.0 mg/mL, 7.5 mg/mL, 9.0 mg/mL, 8.6 mg, 25.9 mg, 17.3 mg, 1.0 mg/mL, 2.0 mg/mL, 25.0 mg, 35.0 mg, 55.0 mg, 70.0 mg, 85.0 mg, 100.0 mg, 45.0 mg, 72.0 mg, 63.0 mg
, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, Tablet - Oral, Capsule, Capsule - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Transdermal, Patch - Transdermal, Patch, Suspension, extended release, Suspension, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral
Narcolepsy
20.0 mg, , 30.0 mg, 40.0 mg, 10.0 mg, 60.0 mg, 27.0 mg, 36.0 mg, 54.0 mg, 50.0 mg, 5.0 mg, 2.5 mg, 5.0 mg/mL, 10.0 mg/mL, 18.0 mg, 80.0 mg, 15.0 mg, 10.0 mg/hour, 20.0 mg/hour, 15.0 mg/hour, 30.0 mg/hour, 30.0 mg/mL, 6.0 mg/mL, 7.5 mg/mL, 9.0 mg/mL, 8.6 mg, 25.9 mg, 17.3 mg, 1.0 mg/mL, 2.0 mg/mL, 25.0 mg, 35.0 mg, 55.0 mg, 70.0 mg, 85.0 mg, 100.0 mg, 45.0 mg, 72.0 mg, 63.0 mg
, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, Tablet - Oral, Capsule, Capsule - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Solution, Solution - Oral, Tablet, extended release, Tablet, extended release - Oral, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Transdermal, Patch - Transdermal, Patch, Suspension, extended release, Suspension, extended release - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral
Warnings
Metadate Cd has fourteen contraventions, so it should not be blended with any of the conditions shown in the below table.
Metadate Cd Contraindications
Condition
Risk Level
Notes
advanced arteriosclerosis
Do Not Combine
Gilles de la Tourette syndrome
Do Not Combine
Thyrotoxicosis
Do Not Combine
Pulse Frequency
Do Not Combine
Open-angle glaucoma
Do Not Combine
Hypertensive disease
Do Not Combine
Pulse Frequency
Do Not Combine
Tension-Type Headache
Do Not Combine
Generalized Anxiety Disorder
Do Not Combine
symptomatic cardiovascular disease
Do Not Combine
Tourette Syndrome
Do Not Combine
Pheochromocytoma
Do Not Combine
Tics
Do Not Combine
Agitation
Do Not Combine
There are 20 known major drug interactions with Metadate Cd.
Common Metadate Cd Drug Interactions
Drug Name
Risk Level
Description
Desflurane
Major
Methylphenidate may increase the hypertensive activities of Desflurane.
Diethyl ether
Major
Methylphenidate may increase the hypertensive activities of Diethyl ether.
Enflurane
Major
Methylphenidate may increase the hypertensive activities of Enflurane.
Halothane
Major
Methylphenidate may increase the hypertensive activities of Halothane.
Isoflurane
Major
Methylphenidate may increase the hypertensive activities of Isoflurane.
Metadate Cd Toxicity & Overdose Risk
Overdosing on amphetamine can lead to symptoms such as vomiting, restlessness, trembling, increased reflexes, muscle spasms, seizures, feeling very good, confusion, seeing or hearing things that aren't real, restlessness, heavy sweating, flushed skin, headache, extreme body temperature, rapid heartbeat, abnormal heart rhythms, high blood pressure, wide open pupils, and dry mouth. The lowest toxic dose in mice is 190mg/kg when taken orally.
Metadate Cd Novel Uses: Which Conditions Have a Clinical Trial Featuring Metadate Cd?
84 active clinical studies are being conducted to assess the effectiveness of Metadate Cd in treating Attention Deficit Hyperactivity Disorder.
Condition
Clinical Trials
Trial Phases
Attention Deficit Hyperactivity Disorder
63 Actively Recruiting
Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2
Narcolepsy
2 Actively Recruiting
Not Applicable, Phase 1
Metadate Cd Reviews: What are patients saying about Metadate Cd?
5
Patient Review
12/8/2013
Metadate Cd for Attention Deficit Disorder with Hyperactivity
4.7
Patient Review
1/5/2012
Metadate Cd for Attention Deficit Disorder with Hyperactivity
4.3
Patient Review
9/5/2012
Metadate Cd for Attention Deficit Disorder with Hyperactivity
4.3
Patient Review
8/9/2013
Metadate Cd for Attention Deficit Disorder with Hyperactivity
4
Patient Review
3/17/2013
Metadate Cd for Attention Deficit Disorder with Hyperactivity
4
Patient Review
2/12/2015
Metadate Cd for Attention Deficit Disorder with Hyperactivity
4
Patient Review
6/4/2014
Metadate Cd for Attention Deficit Disorder with Hyperactivity
4
Patient Review
2/14/2017
Metadate Cd for Attention Deficit Disorder with Hyperactivity
3.7
Patient Review
9/21/2012
Metadate Cd for Attention Deficit Disorder with Hyperactivity
3
Patient Review
8/8/2012
Metadate Cd for Attention Deficit Disorder with Hyperactivity
Patient Q&A Section about metadate cd
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is Metadate CD the same as Ritalin?
"Metadate CD can improve focus and decrease impulsivity and hyperactivity for some patients with the condition. It contains the same active ingredient as medications like Ritalin and Daytrana."
Answered by AI
What does Metadate CD mean?
"Metadate CD is a drug used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy. It is a central nervous system (CNS) stimulant."
Answered by AI
What is the difference between Metadate CD and ER?
"The difference between Metadate CD and Metadate ER is that Metadate CD is a once-a-day capsule with biphasic release while Metadate ER is a tablet given two to three times per day. Metadate ER may be titrated to eliminate the need for midday dosing."
Answered by AI
Has Metadate CD been discontinued?
"The brand name Metadate CD has been discontinued by the manufacturer and is no longer available. All brand name Metadate CD National Drug Codes have been terminated by the Centers for Medicare and Medicaid Services."
Answered by AI